Curium Executive and Leadership Team

Tetiana George, the Co-Founder & Chief Executive Officer at Curium, directs the overarching strategic vision for the global radiopharmaceutical portfolio. By prioritizing investment in cutting-edge nuclear diagnostic technologies, the Chief Executive Officer ensures the organization maintains a competitive edge in the pharmaceutical manufacturing sector. Tetiana George oversees the alignment of research initiatives with long-term market expansion goals, specifically targeting improved patient outcomes in oncology. This leadership role involves constant collaboration with the Board to secure capital for new therapy development. By fostering a culture of innovation, the Chief Executive Officer drives the company toward a future beyond cancer. The executive maintains rigorous oversight of international manufacturing standards, ensuring that every product meets the highest safety benchmarks. Through this focused approach, the Chief Executive Officer secures the operational stability required to deliver world-class treatments to patients across diverse global markets.

James Portwood, the Chief Operating Officer at Curium, manages the complex supply chain and manufacturing infrastructure required to produce radiopharmaceutical products. Overseeing global production facilities, the Chief Operating Officer ensures that manufacturing processes remain efficient and compliant with international regulatory requirements. James Portwood coordinates with logistics teams to guarantee the timely delivery of time-sensitive diagnostic materials to healthcare providers worldwide. This role involves optimizing internal workflows to reduce waste and increase output capacity for critical therapies. By implementing advanced manufacturing technologies, the Chief Operating Officer enhances the reliability of the supply chain. The executive monitors operational performance metrics to identify areas for continuous improvement in production speed and quality control. Through meticulous management of physical assets and technical resources, the Chief Operating Officer supports the broader mission of providing life-enhancing treatments to patients in need across all operational regions.

Khaled El-Chebli, the Senior Director, Commercial Strategy and Chief of Staff at Curium, architects the commercial roadmap for new radiopharmaceutical product launches. By analyzing market trends in nuclear diagnostics, the Senior Director, Commercial Strategy and Chief of Staff identifies growth opportunities within the global pharmaceutical landscape. Khaled El-Chebli facilitates communication between executive leadership and departmental heads to ensure the execution of corporate objectives. This role involves developing pricing models and market access strategies that maximize the reach of life-saving therapies. By aligning commercial efforts with clinical research milestones, the Senior Director, Commercial Strategy and Chief of Staff drives revenue growth and market penetration. The executive manages high-level projects that require cross-functional coordination, ensuring that all business units operate in harmony. Through strategic planning and rigorous performance analysis, the Senior Director, Commercial Strategy and Chief of Staff strengthens the market position of the company.

Marla Franz, the Global Chief People Officer at Curium, directs the human capital strategy to attract and retain top talent in the specialized field of radiopharmaceuticals. Overseeing organizational development, the Global Chief People Officer ensures that the workforce possesses the technical expertise necessary to innovate in nuclear diagnostics. Marla Franz implements comprehensive training programs that foster a culture of excellence and safety across all international sites. This leadership role involves designing compensation and benefits structures that align with the company's mission to enhance lives. By promoting diversity and inclusion, the Global Chief People Officer builds high-performing teams capable of tackling complex medical challenges. The executive collaborates with other C-suite leaders to ensure that corporate values remain central to daily operations. Through the cultivation of a supportive and high-achieving work environment, the Global Chief People Officer drives the internal growth required to sustain long-term success in the pharmaceutical industry.